Guided Therapeutics Inc. has announced a new contract with Hangzhou Dongye Medical Technology Company, Ltd. (HDMT) in China. The agreement involves a series of nine payments totaling $700,000 for the LuViva Advanced Cervical Scan components and services. So far, Guided Therapeutics has received $100,000, including a recent $70,000 payment which triggers the shipment of three sets of components to HDMT and the manufacture of four additional sets. Once these are assembled and tested, it will initiate the next payment of $80,000. HDMT, based in Hangzhou City, is the exclusive provider of gynecology products for 42 hospitals, conducting approximately two million cervical cancer screenings annually.
Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Guided Therapeutics Inc. published the original content used to generate this news brief via Business Wire (Ref. ID: 20250819347040) on August 19, 2025, and is solely responsible for the information contained therein.